TYRA - Tyra Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.50
DETAILS
HIGH:
$59.00
LOW:
$42.00
MEDIAN:
$51.50
CONSENSUS:
$50.50
UPSIDE:
55.53%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Operating Expenses | |||||||
| R&D Expenses | 102.9 | 80.1 | 62.5 | 43.0 | 20.6 | 7.2 | 1.8 |
| SG&A Expenses | 29.8 | 24.1 | 17.4 | 15.9 | 5.7 | 2.1 | 1.3 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Operating Expenses | 132.8 | 104.2 | 79.9 | 58.9 | 26.3 | 9.2 | 3.1 |
| Operating Income | |||||||
| Operating Income | (132.8) | (104.2) | (79.9) | (58.9) | (26.3) | (9.3) | (3.1) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Interest Income | 12.8 | 17.7 | 10.8 | 3.7 | 0.0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (132.2) | (103.7) | (79.6) | (58.6) | (26.1) | (9.2) | (3.1) |
| EBIT | (132.8) | (104.2) | (79.9) | (58.9) | (26.3) | (9.3) | (3.1) |
| Income Before Tax | (119.9) | (86.5) | (69.1) | (55.3) | (26.3) | (9.3) | (4.1) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (119.9) | (86.5) | (69.1) | (55.3) | (26.3) | (9.3) | (4.1) |
| Per Share Data | |||||||
| EPS (Basic) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| Shares Outstanding | 59.6 | 57.2 | 42.7 | 41.9 | 41.4 | 42.5 | 42.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 77.4 | 92.0 | 58.0 | 251.2 | 302.2 | 15.2 | 0.1 |
| Short-Term Investments | 178.6 | 249.5 | 145.5 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.4 | 4.0 | 8.2 | 6.1 | 0 | 0 | 0 |
| Total Current Assets | 265.4 | 347.5 | 211.7 | 257.3 | 304.1 | 15.3 | 0.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 6.9 | 7.7 | 8.2 | 3.5 | 2.1 | 0.5 | 0.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 |
| Other Non-Current Assets | 10.3 | 8.4 | 6.0 | 5.3 | 0.6 | 0.0 | 0.1 |
| Total Non-Current Assets | 17.2 | 16.1 | 14.2 | 8.9 | 2.6 | 0.7 | 0.4 |
| Total Assets | 282.6 | 363.6 | 225.9 | 266.2 | 306.7 | 16.0 | 0.5 |
| Current Liabilities | |||||||
| Account Payables | 1.2 | 0.6 | 4.7 | 1.1 | 0.6 | 0.7 | 0.3 |
| Short-Term Debt | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 16.4 | 13.6 | 5.3 | 0 | 0 | 0.3 | 4.3 |
| Total Current Liabilities | 18.1 | 14.6 | 15.3 | 5.7 | 3.6 | 1.9 | 5.2 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 5.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0.0 | 0.0 | 0.2 | 0.4 | 27.8 | 0 |
| Total Non-Current Liabilities | 5.3 | 5.8 | 6.3 | 2.7 | 1.3 | 27.8 | 0.1 |
| Total Liabilities | 23.4 | 20.4 | 21.6 | 8.4 | 5.0 | 29.6 | 5.3 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (371.3) | (251.3) | (164.8) | (95.7) | (40.4) | (14.1) | (4.7) |
| Accumulated Other Comprehensive Income | 0.4 | 0.8 | 0.4 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 259.2 | 343.2 | 204.3 | 257.8 | 301.7 | (13.6) | (4.7) |
| Total Liabilities & Equity | 282.6 | 363.6 | 225.9 | 266.2 | 306.7 | 16.0 | 0.5 |
| Debt Metrics | |||||||
| Total Debt | 5.8 | 6.2 | 6.5 | 2.6 | 1.2 | 0.1 | 0.3 |
| Net Debt | (71.6) | (85.7) | (51.5) | (248.6) | (301.0) | (15.1) | 0.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (119.9) | (86.5) | (69.1) | (55.3) | (26.3) | (9.3) | (4.1) |
| Depreciation & Amortization | 0.5 | 0.5 | 0.4 | 0.3 | 0.1 | 0.0 | 0.0 |
| Stock-Based Compensation | 28.0 | 22.8 | 0 | 10.6 | 2.9 | 0.4 | 0 |
| Change in Working Capital | (1.6) | (0.7) | 6.4 | (5.8) | (0.5) | 1.1 | 0.5 |
| Other Non-Cash Items | (2.1) | (5.9) | 12.3 | 0.0 | 0.0 | 0.0 | 0.9 |
| Operating Cash Flow | (95.1) | (69.8) | (50.1) | (50.3) | (23.7) | (7.8) | (2.6) |
| Investing Activities | |||||||
| Capital Expenditure | (0.1) | (0.7) | (0.8) | (0.6) | (0.7) | (0.3) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Purchases of Investments | (101.3) | (263.6) | (143.8) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 173.9 | 165.9 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Investing Cash Flow | 72.5 | (98.4) | (144.6) | (0.6) | (0.6) | (0.3) | (0.0) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (0.0) | (0.0) | (0.0) |
| Stock Repurchased | 0 | (0.4) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 2.6 | 0 | 0 | 0.5 | 0.1 | 0.2 |
| Financing Cash Flow | 8.1 | 202.1 | 1.5 | 0.6 | 311.3 | 23.4 | 0.2 |
| Cash Position | |||||||
| Net Change in Cash | (14.6) | 34.0 | (193.2) | (51.0) | 287.0 | 15.4 | (2.5) |
| Cash at Beginning | 93.0 | 59.0 | 251.2 | 302.2 | 15.5 | 0.1 | 2.6 |
| Cash at End | 78.4 | 93.0 | 58.0 | 251.2 | 302.4 | 15.5 | 0.1 |
| Free Cash Flow | (95.3) | (70.4) | (50.9) | (50.8) | (24.4) | (8.1) | (2.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Operating Income | (132.8) | (104.2) | (79.9) | (58.9) | (26.3) | (9.3) | (3.1) |
| Net Income | (119.9) | (86.5) | (69.1) | (55.3) | (26.3) | (9.3) | (4.1) |
| EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| Balance Sheet | |||||||
| Cash & Equivalents | 77.4 | 92.0 | 58.0 | 251.2 | 302.2 | 15.2 | 0.1 |
| Total Assets | 282.6 | 363.6 | 225.9 | 266.2 | 306.7 | 16.0 | 0.5 |
| Total Debt | 5.8 | 6.2 | 6.5 | 2.6 | 1.2 | 0.1 | 0.3 |
| Stockholders' Equity | 259.2 | 343.2 | 204.3 | 257.8 | 301.7 | (13.6) | (4.7) |
| Cash Flow | |||||||
| Operating Cash Flow | (95.1) | (69.8) | (50.1) | (50.3) | (23.7) | (7.8) | (2.6) |
| Capital Expenditure | (0.1) | (0.7) | (0.8) | (0.6) | (0.7) | (0.3) | (0.0) |
| Free Cash Flow | (95.3) | (70.4) | (50.9) | (50.8) | (24.4) | (8.1) | (2.6) |